← ProjMedArchiveSign in

ProjMed article archive

Every ProjMed story ships with clinician, investor, and patient lenses; ELI5 and regulatory depth; and an evidence grade.

Closing the Epilepsy Treatment Gap: Why Stigma and Access Undermine Innovation
opinion·Grade C

Closing the Epilepsy Treatment Gap: Why Stigma and Access Undermine Innovation

Despite significant progress in antiepileptic drugs and device therapies, a substantial portion of epilepsy patients globally remain untreated or inadequately managed, often due to social stigma and systemic healthcare access issues rather than a lack of medical solutions.

ProjMed Editorial DeskJul 18 · 5 min